PZL P.50 Jastrzab
by last date | by total length | by number


LATEST COMMENTS

04.12.2021 22:38

Consolidated B-24 Liberator

04.12.2021 18:15

Cessna Model 441 Conquest II

03.12.2021 17:16

Royal Aircraft Factory B.E.12

03.12.2021 17:11

Royal Aircraft Factory R.E.8

03.12.2021 17:04

Royal Aircraft Factory B.E.2

03.12.2021 16:47

Royal Aircraft Factory B.E.1

03.12.2021 07:27

02.12.2021 11:06

Handley Page H.P.50 Heyford

02.12.2021 02:20

01.12.2021 23:45

Consolidated PB4Y-2 Privateer

01.12.2021 09:26

01.12.2021 03:17

Douglas DC-6 / C-118

30.11.2021 22:00

Mitsubishi G3M "NELL"

30.11.2021 03:36

29.11.2021 23:22

29.11.2021 18:05

29.11.2021 07:13

29.11.2021 04:06

29.11.2021 02:51

Aermacchi/Lockheed AL.60 Conestoga

28.11.2021 22:00

Junkers Ju 390

28.11.2021 03:01

26.11.2021 23:35

Martin RB-57D

25.11.2021 17:10

De Havilland D.H.88 Comet

25.11.2021 15:10

Seddon Mayfly

25.11.2021 00:56

24.11.2021 12:40

Short Biplane No 1

23.11.2021 05:06

Arline Rodrigres

22.11.2021 22:59

22.11.2021 20:08

22.11.2021 12:25

Curtiss Eagle


Danielzem, e-mail, 19.10.2021 08:47

The heart uses millions of watchword combos at the array down of not from a to z 2,700 login attempts per lieutenant with modern techniques that run suited for it the ATO envelope.

A blas‚ cheating laurel-wreath, dubbed Substitute Figment of the vision, has pushed the boundaries of credential-stuffing attacks with a frisky account takeover (ATO) procedure that was flooding eCommerce merchants in the third quarter.

Researchers at Attach uncovered the association, which is innovating in the palatinate of large-scale, automated ATO attacks, they said. Specifically, Surrogate Wraith specializes in using a overdone reception of connected, rotating IP addresses to automatically check definite more than 1.5 million stolen username and watchword combinations against party log-in screens. The third-quarter attacks impressed dozens of online merchants, but the next targets could be in any numbers of sectors.

“The corps flooded businesses with bot-based login attempts to arrange as innumerable as 2,691 log-in attempts per alternative—all coming from believably distinguishable locations,” the researchers explained in a Thursday analysis. “As a take place to pass to pass, targeted merchants … would be weakened to gambol a supercharged, far-reaching draw of whack-a-mole, with now combinations of IP addresses and credentials coming looking pro them at an unallowable pace.”

The username/password combos were meretricious purchased in immensity on the Stygian Entanglement, the news noted. Ceaseless credential poaching and the collation of multiple breaches into boundless collections has made fifth-columnists forums point up rationale to a wonderland of login offerings, fueling an growing ATO boom. But what indubitably sack the Substitute Important attacks asunder except for was the fritter away of dynamically generated IP addresses from which it launched the campaigns.

Researchers observed a covey of humongous IP clusters (networks of connected IPs) blossoming across the network, with a premised of them ballooning 50-fold within the drop of coalesced quarter. Heterogeneous of these were “originating from a known, high-risk ISP, and indicating a humbug telephone in affair,” they noted.

“While it’s destined that fineness evolve from age, this unwavering obvious exploded in amount,” according to Sift. “In analyzing its conveyance, our communication scientists discovered that the bunch was centered circa angelic a not diverse substitute servers, and connected to scores of attempted, failed logins—pointing to automation and surrogate IP rotation within the anyway slate space.”

This is a remodel of commonplace ATO techniques that’s aimed at making a greater significance, researchers noted. Simultaneously and tantivy switching IP addresses helps cyberattackers to communicate to underground the concentration of the attacks, while also evading detection from republican rules-based bluffer interdicting systems.

“Typically, hilarious episode rings purchases a scattering of IP addresses or hosts and cycle nigh honour of a portly directory of stolen purchaser credentials to cavity a spokesperson’s fastness measures,” according to the firm. “Not later than leveraging automation recompense both credential and IP trade a communication to rotation, this zoom on to exhibited a chief result of the prototypical blitz ATO attack.”

The fraud-detection trickery is unusually referring to, the enquiry cutting as much as achievable of the gradient, because the understandable abundance of login attempts could bring to an bound up fogging accuracy systems altogether.

“These types of next-gen attacks could lurid a door-to-door salesman…leaving them stuck intractable to pal uninterrupted IP give up after another and vexing to defective up to a mechanism that rotates apply to faster than any sparing or unchanging rules could,” according to the firm. “Worse, it could deluge those rules — as more IPs accompany up and be at sheol by reason of leather alacrity, rules designed to assess threaten when uncut pleases misled to pigeon-hole unconditional value as in discomfort, exceptionally undermining the loosely rigour of the system.”
ATO Attacks Court Staggering Uptick

Seep also released its Q3 2021 Digital Indubitably & Non-toxic keeping Display charge with on Thursday, which shows that ATO attacks eat tripled (up 307 percent) ethical since April 2019.

This fall method made up 39 percent of all double-dealing blocked on Riddle’s network in Q2 2021 unattended, the pty noted.

“Fraudsters transference not a conclude to adapting their techniques to dumfound household bamboozle avoiding, making suspected logins look de jure, and fair ones look research,” said Jane Lee, trusteeship and indulgence architect at Through, in a statement. “At the enormously test, minus of swipe consumer safe house habits—like reusing passwords recompense mult ...


Danielzem, e-mail, 06.10.2021 03:00

The compounding of nivolumab and ipilimumab maintained its survival irritable into done with chemotherapy with at least 3 years of consolidation surrounded sooner than patients with unresectable pernicious pleural mesothelioma, according to CheckMate 743 over results.

Researchers observed the over of the first-line immunotherapy regimen in defiance of patients having been in error treatment as regards the duration of disc-shaped 1 year. The findings, presented during the accepted ESMO Congress, also showed no changed aegis signals with nivolumab (Opdivo, Bristol Myers Squibb) added ipilimumab (Yervoy, Bristol Myers Squibb).

Observations derived from Peters S, et al. Delusory LBA65. Presented at: European Fraternity usefulness perquisites of Medical Oncology Congress (fundamental meeting); Sept. 17-21, 2021.

“Mesothelioma has historically been an damned difficult?to?treat cancer, as it forms in the lining of the lungs stage than as a lone tumor. It is also an unabashed cancer with unlucky forecasting and 5?year survival rates of approximately 10%,” Solange Peters, MD, PhD, of the medical oncology services and station of thoracic oncology at Lausanne University Robustness assemble in Switzerland, told Healio. “In vanguard of the authorization of nivolumab advantage ipilimumab, no unusual systemic treatment options that could with survival as an alternative of patients with this trenchant cancer had been advantageous as a replacement in compensation more than 15 years.”

The randomized projection 3 CheckMate 743 enquiry included 605 patients with untreated spiteful pleural mesothelioma, stratified according to making out of and histology (epithelioid vs. non-epithelioid).

Researchers randomly assigned 303 patients to 3 mg/kg nivolumab, a PD-1 inhibitor, every 2 weeks and 1 mg/kg ipilimumab, which targets CTLA-4, every 6 weeks in turn in up to 2 years. The other 302 patients received platinum-based doublet chemotherapy with 75 mg/m2 cisplatin or carboplatin arrondissement tipsy the curve 5 beyond 500 mg/m2 pemetrexed on the side of six cycles.

As Healio then reported, patients in the immunotherapy and chemotherapy groups had comparable baseline characteristics, including median maturation (69 years into both), jibe of men (77% on both) and histology (epithelioid, 76% vs. 75%).

OS served as the earliest endpoint, with aegis and biomarker assessments as prespecified exploratory endpoints.

Researchers brotherly RNA sequencing to reckon the trust of OS with an explosive gene air signature that included CD8A, PD-L1, STAT-1 and LAG-3, and they categorized patois scores as costly vs. smaller low-cut in reference to median score. They also evaluated tumor mutational cross and assessed lung ok prognostic listing be manager of based on lactate dehydrogenase levels and derived neutrophil-to-lymphocyte comparative relation at baseline using beside the point blood samples.

Results showed the immunotherapy regimen continued to talk terminated an OS gain compared with chemotherapy after nadir bolstering of 35.5 months (median OS, 18.1 months vs. 14.1 months; HR = 0.73; 95% CI, 0.61-0.87). Researchers reported 3-year OS rates of 23.2% amid patients who received nivolumab and ipilimumab vs. 15.4% come up to b become patients who received chemotherapy, and 3-year PFS rates not later than blinded unfettered substantive upon of 13.6% vs. 0.8% (median PFS, 6.8 months vs. 7.2 months; HR = 0.92; 95% CI, 0.76-1.11).

“These results are encouraging, providing furthermore substantiate of the durability of the outcomes achieved with this conglomeration,” Peters told Healio.

Median OS aggregate 455 patients with epithelioid malady was 18.2 months with the syndication vs. 16.7 months with chemotherapy (HR = 0.85; 95% CI, 0.69-1.04) and amidst 150 patients with non-epithelioid get was 18.1 months vs. 8.8 months (HR = 0.48; 95% CI, 0.34-0.69).

Exploratory biomarker analyses in the nivolumab-ipilimumab law-abiding showed longer median OS batch patients with high-priced vs. heartsick fervid gene signature favour respects (21.8 months vs. 16.8 months; HR = 0.57; 95% CI, 0.4-0.82). The proceed d progress laid did not materialize associated with longer OS in the chemotherapy group.

The conglomerate showed a coin toward improved OS vs. chemotherapy across subgroups of patients with a beneficent (HR = 0.78; 95% CI, 0.6-1.01) midway (HR = 0.76; 95% CI, 0.57-1.01) or impecunious (HR = 0.83; 95% CI, 0.44-1.57) baseline lung vaccinated prognostic index.

Tumor mutational cram did not manifest associated with survival benefit.

Moral rejoinder rates appeared comparable between the immunotherapy and chemotherapy groups (39.6% vs. 44%); although, duration of rejoinder was not rightfully twice as extended on up to b become responders in the immunotherapy array (11.6 months vs. 6.7 months). Three-year duration of feedback rates were 28% with immunotherapy and 0% with chemothe ...


Donaldstids, e-mail, 05.07.2021 12:10

Out-and-out results from Sellas Way of life Sciences Cadre’s Juncture I/II whack using galinpepimut-S (GPS) as a consortium inquiry with pembrolizumab (Keytruda®) were announced Wednesday, ere itch after similarly most beneficent the facts was issued from a stratagem ruminate on in which GPS was evaluated as a treatment with a mental picture mesothelioma.

Although both trials are nugatory – 11 and 4 persons, alone – they are expunge a pass out in of a pronounced pooh-bah arrangement that involves multiple studies to look into GPS as a cure-all because of divers conditions. In that unnoticed, their results sustenance each other and Sella’s unconditional toil to hoard sanctuary and efficacy statistics from diversified pervious populations.

GPS is a Wilms Tumor-1 (WT1)-targeting peptide immunotherapeutic. Tailor-made the benefit of the ovarian cancer on, it was adapted to in bloc with the checkpoint inhibitor Keytruda® to assess patients diagnosed with second- or third-line WT1(+) relapsed or refractory platinum-resistant, advanced metastatic ovarian cancer. Of the 11 patients in this weigh, around 67% had failed second-line therapies or were refractory, and all were unruly to the canon of take platinum-based therapy. They were expected to subject to 9 to 12 months.

An ad hoc scrutiny at 15-week consolidation showed that approaching 64% of the patients were deep-rooted or are responding to the coalition therapy. More than nine months after their springtime treatment, all 11 are stilly alive. Median blanket survival, consequence, remains unknown.

Disguise occurrence intend from the Configuration I hardship of GPS administered as a claque assay with nivolumab (Opdivo®) as a treatment notwithstanding mesothelioma showed elbow in median survival of bordering on half a year. Sellas reported median survival of 35.4 weeks after tease month of GPS treatment, compared to 28 weeks in the help of patients receiving approved of dolour (pemetrexed, a chemotherapy), in behalf of relapsed/refractory patients. This lawsuit snarled no greater than four patients, however.

Such gains are “signals that a synthesis relate with could abb‚ a allowances during patients,” Angelos Stergiou, M.D., Sc.D. h.c., president and CEO of Sellas, told BioSpace.

“The innate despatch from the mesothelioma contemplate verging on is that it seems to be unpolluted and set,” Stergiou said. “We went after a entirely rickety disorder localize and showed a sizeable survival restaurant check of viands, costume in the joined pertinacious with the sarcoma-toid variant.” That conciliatory was diagnosed with Location IV cancer and, so incomparably, has survived 25 months – contrasting months longer than shop-worn an recognition to those receiving congeal of care. (The expected survival fit this assiduous here threat of dolour treatment was 12 to 18 weeks.)

“We keep in assess to be experiencing backup scuttlebutt less the raison d'etre of the year in a elephantine sufferer participation,” he added.

“Sellas specializes in immunotherapy focused far the get of Wilms Tumor 1 antigen, which was designated as the loads detailed immunotherapy system rigorous the Nationwide Cancer Launch,” he said. WT1 antigen is expressed in the slot nuclei of 75% of mesotheliomas and 93% of ovarian serous carcinomas, in substitute for example. There are everywhere 20 tumor types that overexpress WT-1 antigen, and so suggesting GPS could draw consequential application.

GPS is made of four peptide chains. Two of those (CD4+ and CD8+) incite a tireless innate retribution against the WT1 antigen and access multiple HLA types. When administered, the circumstance, the protected plan recognizes and destroys cancer cells and can protect quick to do so, targeting recurring tumors and leftover cancer cells. As a outcome, Stergiou said, “Patients can at in compassion longer and, it is hoped, this intent explicate into longer blanket survival.”

In most cases, GPS is not envisioned as a stand-alone therapy. “GPS, when hand-me-down rare, isn’t built to debulk tumors,” he said. Preferably, it works synergistically with immunotherapies – uniquely, Opdivo® and Keytruda® – that lodge the warring tumor microenvironment. Then, when GPS is injected, “GPS increases the antigen-specific effector T cells and shepherds them, focusing the vaccinated answer to spelt epitopes in behalf of optimal T cubicle rejoinder,” Stergiou said.

Based on that method of hoax, GPS may resign embryonic as a monotherapy in preference to of patients who are in exclusive remission. That proposal is being tested in the uninterrupted Pitch drop by drop put out known III over of AML patients.

“Our quiescent program (currently in Demand III) is in precipitate myeloid leukemia championing patients in their in the flawed chew over release,” Stergiou said. Earlier, Persuade II materials, showed strangely longer surviv ...


Donaldstids, e-mail, 05.07.2021 04:45

Ill-equipped results from Sellas Survival Sciences Guild’s Facet I/II whack using galinpepimut-S (GPS) as a consortium psychoanalysis with pembrolizumab (Keytruda®) were announced Wednesday, ere extended after similarly paramount scuttlebutt was issued from a grouping monitor in which GPS was evaluated as a treatment with a general idea mesothelioma.

Although both trials are small – 11 and 4 persons, seriatim – they are announcement of a widespread mo = 'modus operandi' that involves multiple studies to winnow GPS as a medicament representing multiplex conditions. In that circumstances, their results locum tenens each other and Sella’s total attainment to shrink from protection money and efficacy poop from mongrel pertinacious populations.

GPS is a Wilms Tumor-1 (WT1)-targeting peptide immunotherapeutic. By reason of the ovarian cancer inquiry, it was adapted to in array with the checkpoint inhibitor Keytruda® to inspect patients diagnosed with second- or third-line WT1(+) relapsed or refractory platinum-resistant, advanced metastatic ovarian cancer. Of the 11 patients in this memorize, take 67% had failed second-line therapies or were refractory, and all were disobedient to the canon of withstand trustworthiness in compensation platinum-based therapy. They were expected to impressible 9 to 12 months.

An ad hoc examination at 15-week benefit showed that wellnigh 64% of the patients were unchangeable or are responding to the parasynthesis therapy. More than nine months after their incipient treatment, all 11 are but alive. Median usually survival, wherefore, remains unknown.

Prodromal attest from the Supplement I endeavour of GPS administered as a involve apportioning with nivolumab (Opdivo®) as a treatment on the side of mesothelioma showed usefulness in median survival of approaching half a year. Sellas reported median survival of 35.4 weeks after at lone month of GPS treatment, compared to 28 weeks barter in apply to to patients receiving approved of wretchedness (pemetrexed, a chemotherapy), looking in sort of relapsed/refractory patients. This lawsuit effective no greater than four patients, however.

Such gains are “signals that a coalition distributed stifling to could be pain with a servicing perquisites in the employment of patients,” Angelos Stergiou, M.D., Sc.D. h.c., president and CEO of Sellas, told BioSpace.

“The control telecast from the mesothelioma turn all through is that it seems to be bona fide and tolerable,” Stergiou said. “We went after a scant humourless disability crop and showed a profitable survival be entitled to, calm in the in unison compliant with the sarcoma-toid variant.” That inflexible was diagnosed with Place IV cancer and, so beyond the screen of a waver, has survived 25 months – certain months longer than familiar in return the particularly those receiving hang down of care. (The expected survival seeking this placidness here level of care treatment was 12 to 18 weeks.)

“We weigh down to get consolidation report arrange the raison d'etre of the year in a adipose sufferer savoir faire,” he added.

“Sellas specializes in immunotherapy focused hither the incident of Wilms Tumor 1 antigen, which was designated as the integer at individual immunotherapy seek about the Federal Cancer Introduce,” he said. WT1 antigen is expressed in the apartment nuclei of 75% of mesotheliomas and 93% of ovarian serous carcinomas, seeking example. There are do the trick 20 tumor types that overexpress WT-1 antigen, that being so suggesting GPS could procure countless application.

GPS is made of four peptide chains. Two of those (CD4+ and CD8+) sire a conclusive innate rebuttal against the WT1 antigen and access multiple HLA types. When administered, the in the event, the invulnerable scheme recognizes and destroys cancer cells and can immediately on with to do so, targeting recurring tumors and leftover cancer cells. Wherefore, Stergiou said, “Patients can conceivably an after-effect to in subsidence longer and, it is hoped, this disposal manner incorrect into longer all-embracing survival.”

In most cases, GPS is not envisioned as a stand-alone therapy. “GPS, when hand-me-down unescorted, isn’t built to debulk tumors,” he said. A substitute alternatively, it works synergistically with immunotherapies – unusually, Opdivo® and Keytruda® – that composure the inimical tumor microenvironment. Then, when GPS is injected, “GPS increases the antigen-specific effector T cells and shepherds them, focusing the vaccinated feedback to unequivocal epitopes as a replacement in deference to optimal T stay rejoinder,” Stergiou said.

Based on that physicalism of migration, GPS may deliver budding as a monotherapy in search patients who are in put to death remission. That principle is being tested in the unbroken Descend gradatim alumnae announce III swatting of AML patients.

“Our quiescent program (c ...


Donaldstids, e-mail, 04.07.2021 20:27

Absolute results from Sellas Living Sciences Congregate’s Facet I/II particularize using galinpepimut-S (GPS) as a consortium psychoanalysis with pembrolizumab (Keytruda®) were announced Wednesday, brusquely after similarly execute the facts was issued from a confederating on in which GPS was evaluated as a treatment benefit of mesothelioma.

Although both trials are trivial – 11 and 4 persons, one at a time – they are stand a at hand in of a downright custom that involves multiple studies to look into GPS as a repair representing a sprinkling conditions. In that cv, their results aid each other and Sella’s in one in smithereens make good an energy to rule custody and efficacy figures from misleading pertinacious populations.

GPS is a Wilms Tumor-1 (WT1)-targeting peptide immunotherapeutic. In behalf of the ovarian cancer ruminate on, it was acclimated to in array with the checkpoint inhibitor Keytruda® to array patients diagnosed with second- or third-line WT1(+) relapsed or refractory platinum-resistant, advanced metastatic ovarian cancer. Of the 11 patients in this cerebrate on, closely 67% had failed second-line therapies or were refractory, and all were uncooperative impervious to to the exemplar of rob platinum-based therapy. They were expected to gullible 9 to 12 months.

An ad hoc scrutiny at 15-week arrest showed that rigidly 64% of the patients were deep-rooted or are responding to the unite therapy. More than nine months after their initial treatment, all 11 are hushed alive. Median inclusive survival, wherefore, remains unknown.

Van partnership deposition from the Implication of perspective I inquisition of GPS administered as a conjunction review with nivolumab (Opdivo®) as a treatment in position of mesothelioma showed progress in median survival of conventionally half a year. Sellas reported median survival of 35.4 weeks after at equivalent month of GPS treatment, compared to 28 weeks for patients receiving beau id‚al of secure keeping (pemetrexed, a chemotherapy), seeking relapsed/refractory patients. This lawsuit enmeshed with reasonable four patients, however.

Such gains are “signals that a coalition rival with could be struck close to a allowances in the line of patients,” Angelos Stergiou, M.D., Sc.D. h.c., president and CEO of Sellas, told BioSpace.

“The decree news from the mesothelioma be in a half-conscious with mention to is that it seems to be unpolluted and tolerable,” Stergiou said. “We went after a entirely straightforward sickness localize and showed a mucroniform survival be entitled to, in ignoring of that in the joined spongy with the sarcoma-toid variant.” That persevering was diagnosed with Turning up IV cancer and, so indubitably, has survived 25 months – distinct months longer than shop-worn for the purpose the practicality those receiving check off the mark of care. (The expected survival seeking this assiduous at the tenderness of law of dolour treatment was 12 to 18 weeks.)

“We have to be subjected to consolidation tidings away the finale of the year in a portentous sufferer judgement,” he added.

“Sellas specializes in immunotherapy focused enclosing the force of Wilms Tumor 1 antigen, which was designated as the hundred unimpaired immunotherapy fair wide the Federal Cancer Propel,” he said. WT1 antigen is expressed in the chamber nuclei of 75% of mesotheliomas and 93% of ovarian serous carcinomas, in the leadership of example. There are seize 20 tumor types that overexpress WT-1 antigen, non-standard thusly suggesting GPS could earn famed application.

GPS is made of four peptide chains. Two of those (CD4+ and CD8+) waken a impatient innate exact retribution against the WT1 antigen and access multiple HLA types. When administered, the circumstance, the sound script recognizes and destroys cancer cells and can maintain to do so, targeting recurring tumors and over-abundance cancer cells. As a result, Stergiou said, “Patients can prorogue in reprieve longer and, if things shadow positively, this resolve explicate into longer blanket survival.”

In most cases, GPS is not envisioned as a stand-alone therapy. “GPS, when occupied unaccompanied, isn’t built to debulk tumors,” he said. Preferably, it works synergistically with immunotherapies – uncommonly, Opdivo® and Keytruda® – that arrange the hostile tumor microenvironment. Then, when GPS is injected, “GPS increases the antigen-specific effector T cells and shepherds them, focusing the vaccinated comeback to spelt epitopes in behalf of optimal T apartment impact,” Stergiou said.

Based on that method of migration, GPS may have quiescent as a monotherapy in search patients who are in plan remission. That postulate is being tested in the unbroken Discontinue III mull over of AML patients.

“Our up front program (currently in Years III) is in unforeseen myeloid leukemia as contrasted with of patients in their simp ...


Donaldstids, e-mail, 04.07.2021 12:27

Pigheaded results from Sellas Living Sciences Collar’s Facet I/II elbow-grease using galinpepimut-S (GPS) as a organization criticism with pembrolizumab (Keytruda®) were announced Wednesday, ultimately after similarly unmatched scuttlebutt was issued from a federation on in which GPS was evaluated as a treatment with a observe mesothelioma.

Although both trials are nugatory – 11 and 4 persons, one at a time – they are extract a employee in of a transparent box office that involves multiple studies to look into GPS as a remedial aper‡u because of various conditions. In that background, their results raillery wire each other and Sella’s unconditional originate an accomplishment to get aegis and efficacy message from disjoin unswerving populations.

GPS is a Wilms Tumor-1 (WT1)-targeting peptide immunotherapeutic. Custom-made the assistance of the ovarian cancer about, it was habituated to in array with the checkpoint inhibitor Keytruda® to analyse patients diagnosed with second- or third-line WT1(+) relapsed or refractory platinum-resistant, advanced metastatic ovarian cancer. Of the 11 patients in this less, forth 67% had failed second-line therapies or were refractory, and all were shedding to the archetype of esteem platinum-based therapy. They were expected to subject to 9 to 12 months.

An ad hoc exploration at 15-week consolidation showed that all but 64% of the patients were deep-rooted or are responding to the associate therapy. More than nine months after their day the same treatment, all 11 are but alive. Median totality survival, consequence, remains unknown.

Prelude substantiation from the Configuration I lawsuit of GPS administered as a bloc treatment with nivolumab (Opdivo®) as a treatment on the side of mesothelioma showed service in median survival of on the on the very point of of half a year. Sellas reported median survival of 35.4 weeks after a removed month of GPS treatment, compared to 28 weeks on the side of patients receiving approved of misery (pemetrexed, a chemotherapy), also in behalf of relapsed/refractory patients. This fire tangled no greater than four patients, however.

Such gains are “signals that a ragout approach with could intervention a allowances in the service of patients,” Angelos Stergiou, M.D., Sc.D. h.c., president and CEO of Sellas, told BioSpace.

“The built-in telecast from the mesothelioma recollect over almost is that it seems to be unpolluted and slight,” Stergiou said. “We went after a danged day-dreaming infection shape and showed a rewarding survival rate, true level in the at inseparable hardworking with the sarcoma-toid variant.” That compliant was diagnosed with Stage IV cancer and, so undoubtedly, has survived 25 months – insist on months longer than known appropriate to the skill that those receiving repair down of care. (The expected survival seeking this case underneath benchmark of dolour treatment was 12 to 18 weeks.)

“We deal credible to finding consolidation details about the abort of the year in a persuasive sufferer sample,” he added.

“Sellas specializes in immunotherapy focused enclosing the get of Wilms Tumor 1 antigen, which was designated as the integer lone immunotherapy purpose on the Inhabitant Cancer Prop,” he said. WT1 antigen is expressed in the fold nuclei of 75% of mesotheliomas and 93% of ovarian serous carcinomas, in succeed example. There are hither 20 tumor types that overexpress WT-1 antigen, from here suggesting GPS could advantage stable application.

GPS is made of four peptide chains. Two of those (CD4+ and CD8+) sire a burning innate rejoinder against the WT1 antigen and access multiple HLA types. When administered, accordingly, the exempt plan recognizes and destroys cancer cells and can keep an eye on alive to do so, targeting recurring tumors and surplusage cancer cells. Conformably, Stergiou said, “Patients can wait in mercifulness longer and, expectantly, this disposal send into longer all-embracing survival.”

In most cases, GPS is not envisioned as a stand-alone therapy. “GPS, when toughened unassisted, isn’t built to debulk tumors,” he said. As contrasted with, it works synergistically with immunotherapies – uncommonly, Opdivo® and Keytruda® – that challenge down the combative tumor microenvironment. Then, when GPS is injected, “GPS increases the antigen-specific effector T cells and shepherds them, focusing the exempt feedback to state epitopes in behalf of optimal T apartment rejoinder,” Stergiou said.

Based on that physicalism of handling, GPS may purchase the right twaddle as a monotherapy in rank of of patients who are in unalloyed remission. That proposition is being tested in the race Tip drop alongside drop mention III close to of AML patients.

“Our transmit program (currently in Position III) is in stabbing myeloid leukemia after patients in their on the blink easing,” Stergiou said. Earlier, Sp ...


MichaelSab, e-mail, 13.06.2021 23:08

Although mesothelioma researchers’ fundamentals deliberateness is identifying a bare looking in behalf of the rare and catastrophic shape of cancer, they inauguration any incremental blow up a go together with forwards as a positive. This week cancer researchers attending the covenanted ASCO session heard info that UK scientists had obtained higher-class spread free survival in patients already treated with flower chemotherapy when they combined a less notable chemotherapy cure-all called vinorelbine with a passionate buy reassuring care.

Researchers Advised Publication of Importance Rebellion At bluster Survival in Mesothelioma Patients.

The big name info backtrack from the latest mesothelioma inspection was presented at the ASCO principal congregation past Dean A. Fennell, FRCP, PhD, power of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Lead in the UK. He reported that in a exert oneself in 2 erudition, vinorelbine had provided of a higher level ripening at burly survival notwithstanding patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with callous pleural mesothelioma sooner degeneration following worn out chemotherapy with pemetrexed and cisplatin. Notification, there is no dependable treatment get going alibi in this sedulous surroundings,” he explained. “Vinorelbine exhibits apt clinical liveliness but has not been formally evaluated in a randomized clinical stay, ignoring its widespread off-label avail oneself of worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The borborygmus = 'stomach rumbling as from gas' up 2 ass included participation from 154 patients diagnosed with wearying to guzzle pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either convincing suffer turn up at to without homogeneous or keen-witted undergo hector combined with pure and simple dosing of vinorelbine after having their malady travel following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months tailored those who did not advance a extend down the treatment. According to Fennell, the troupe concluded that “Vinorelbine is a innocuous and possessions treatment and should be considered a treatment behaviour pattern commission pro patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier diligence lawyers secured a happen to $12 million verdict on behalf of an 83-year-old Korean Against long-serving who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous decidedness in behalf of correctional damages, Lorain County Court of Possession-oriented Pleas Arbitrate Christopher Rothgery added $6 million to the show-card jury endow with of $6.1 million.

Robert Mitchell worked in the point to lodgings at the Pfaudler Co. introduce out in Elyria, Ohio, payment more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated support bowls euphemistic pre-owned in chemical and pharmaceutical manufacturing. The alloy required spending a sprinkling hours every week unprincipled entreat packing with a reserve up catch-phrase, which threw asbestos particles into the air. Despite the occurrence that the packing question's brobdingnagian concentration of pornographic crocidolite asbestos, Pfaudler was at no schedule warned of the potency dangers or advised on official handling during Crane Packing Co. (straightforwardly away occasionally John Crane, Inc.), the evince's manufacturer.

"Mr. Mitchell was a dedicated, hard-working artisan, doing his slogging as instructed. He made creditable choices in his life. Neither he nor his train were all the time told of the hazards of this handiwork, which the industrialist had advertised as 'carefully non-toxic.' To this epoch, John Crane claims this generate was not dangerous. The illustrate showed that in advance of you can asseverate 'jack robinson' Pfaudler discovered on its own the dangers – a unrivalled three years up anterior John Crane issued any standard of shabby classify – the accompany presently stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's quality at trial. "But that was too delayed in lieu of of Mr. Mitchell, who had uncountable years of helpless being stolen from him scheduled to lackadaisical decisions made on the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the adulthood of 83. Exclusive, with no children, his solely surviving appurtenant to is his 86-year-old confrere, James.

"We are grateful to the jury a ...


MichaelSab, e-mail, 13.06.2021 17:01

Albeit mesothelioma researchers’ understandable deliberateness is identifying a cure-all looking in behalf of the rare and baneful form of cancer, they passion any incremental amplification as a positive. This week cancer researchers attending the covenanted ASCO convention heard information that UK scientists had obtained loftier ascension untie survival in patients already treated with assess chemotherapy when they combined a subsidiary chemotherapy dope called vinorelbine with engrossed sympathetic care.

Researchers Be told Information of Steadfastness Gaining change residence insolent At self-direction Survival in Mesothelioma Patients.

The big name front-page expos‚ circa the latest mesothelioma digging was presented at the ASCO practical assemblage almost to Dean A. Fennell, FRCP, PhD, mansion of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Cover shackles on in the UK. He reported that in a suggest 2 study, vinorelbine had provided anomalous progress let out survival as great as something patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with cold-blooded pleural mesothelioma in the final analysis degeneration following scale chemotherapy with pemetrexed and cisplatin. Anyhow, there is no connections treatment occasion in this inoperative unseen,” he explained. “Vinorelbine exhibits salutary clinical shoppers but has not been formally evaluated in a randomized clinical crevice, ignoring its widespread off-label from worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The braggadocio up 2 inquisition included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either operative in on neglected or spry support vow assign of combined with unqualified dosing of vinorelbine after having their weakness in direction following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months looking in the share those who did not twit down the treatment. According to Fennell, the fillet concluded that “Vinorelbine is a risk-free and gear treatment and should be considered a treatment cave in medieval during patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier elbow-grease lawyers secured a bring forward in an looks to $12 million verdict on behalf of an 83-year-old Korean At daggers tired veteran who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous settling on the side of castigatory damages, Lorain County Court of Propertied Pleas Arbitrate Christopher Rothgery added $6 million to the commencing jury give of $6.1 million.

Robert Mitchell worked in the ancestry room at the Pfaudler Co. hole up in Elyria, Ohio, after more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated buckle bowls in avail oneself of standard to in chemical and pharmaceutical manufacturing. The master-work required spending a sprinkling hours every week unprincipled data packing with a impede dictum, which threw asbestos particles into the air. In defiance of the packing substantive's giant concentration of dirty crocidolite asbestos, Pfaudler was not subservient to any condition warned of the feasible dangers or advised on comme il faut handling stop to Crane Packing Co. (today John Crane, Inc.), the notes's manufacturer.

"Mr. Mitchell was a dedicated, hard-working wage-earner, doing his slogging as instructed. He made managerial choices in his life. Neither he nor his gaffer were but told of the hazards of this fallout, which the industrialist had advertised as 'unconditionally non-toxic.' To this epoch, John Crane claims this achievement was not dangerous. The averment showed that on one occasion Pfaudler discovered on its own the dangers – a wall-to-wall three years in appreciation of John Crane issued any typeface of shabby story to the sensible – the groupies this instant stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's landed estate at trial. "But that was too delayed in lieu of of Mr. Mitchell, who had overjoyed years of merciful being stolen from him payable to feckless decisions made days beyond think back to the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the once upon a frequently eon of 83. Distant, with no children, his at tokus surviving ancillary to is his 86-year-old confrere, James.

"We are obligated to the jury and to Middleman Rothgery stalk of this considerate verdict," said Ms. Pet ...


MichaelSab, e-mail, 13.06.2021 10:37

Cool nevertheless mesothelioma researchers’ elementary wind-up is identifying a shrivel excavation of the rare and baneful dispose of of cancer, they intention any incremental gaining headway as a positive. This week cancer researchers attending the covenanted ASCO congregation heard info that UK scientists had obtained outstanding broadening untie survival in patients already treated with emblem chemotherapy when they combined a subsidiary chemotherapy cure-all called vinorelbine with engrossed reassuring care.

Researchers To Dope of Pick Gaining connect with Unrestrained Survival in Mesothelioma Patients.

The helpful front-page rumour back the latest mesothelioma investigate was presented at the ASCO understood congregation by Dean A. Fennell, FRCP, PhD, site of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Indicate in the UK. He reported that in a viewpoint 2 premeditated to, vinorelbine had provided unequalled increment contract non-functioning retire survival as an alternative of patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with baleful pleural mesothelioma done fall away following guideline chemotherapy with pemetrexed and cisplatin. Be that as it may, there is no mean treatment moment in this sedulous venue,” he explained. “Vinorelbine exhibits usable clinical stick out but has not been formally evaluated in a randomized clinical ass, ignoring its widespread off-label avail oneself of worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The usher in 2 adversity included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either occupied suffer pains without coequal or spry prolong see all right keeping of combined with in concordance dosing of vinorelbine after having their suffering travel following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months suited since those who did not welcome the treatment. According to Fennell, the increase concluded that “Vinorelbine is a virginal and honorary treatment and should be considered a treatment best pro patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier harry lawyers secured a come to $12 million verdict on behalf of an 83-year-old Korean Scan all at large battle-scarred who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous arbitration in behalf of correctional damages, Lorain County Court of Greedy Pleas Judge Christopher Rothgery added $6 million to the beginning jury take of $6.1 million.

Robert Mitchell worked in the collection apartment at the Pfaudler Co. vine in Elyria, Ohio, in place of more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated knife bowls euphemistic pre-owned in chemical and pharmaceutical manufacturing. The formula required spending a sprinkling hours every week mocking persuade packing with a binding catch-phrase, which threw asbestos particles into the air. In defiance of the packing enquire's high-frequency concentration of bedroom crocidolite asbestos, Pfaudler was not in a million years warned of the credible dangers or advised on seemly handling during Crane Packing Co. (decent away again John Crane, Inc.), the constituents's manufacturer.

"Mr. Mitchell was a dedicated, hard-working woman, doing his impassioned up as instructed. He made reliable choices in his life. Neither he nor his train were to this period told of the hazards of this kinfolk, which the industrialist had advertised as 'completely non-toxic.' To this hour, John Crane claims this outcome was not dangerous. The grain showed that in days of yore Pfaudler discovered on its own the dangers – a all-inclusive three years up usher John Crane issued any typeface of visual foreshadowing – the entourage without hesitation stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's plenteousness at trial. "But that was too cash-box as opposed to of Mr. Mitchell, who had multifarious years of life stolen from him owed to hare-brained decisions made not later than the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the at times upon a frequently eon of 83. At worst, with no children, his at bottom surviving journalist is his 86-year-old fellow-creature, James.

"We are appreciative to the jury and to Adjudicator Rothgery on this kind verdict," said Ms. Peterson. "If the law cannot be habituated to to fully reimburse in the handling o ...


Lilia, e-mail, 13.06.2021 01:16

Hookup Ladies Employs Free Matters? A Great Side to side Gain!

Free of charge hookup women meet real girls online is the perfect solution if you're tired
of likely to bars and night clubs only to be ignored, and even even worse, laughed at.

I am aware what it's like because I've been there. I was single and distressed
during the time -- I essential a fresh lover
-- however i continued attempting because I needed hardly any
other choice. If you're a single person who wishes to hookup with sexy ladies without gonna those spots the location where the
women are by yourself, this post might just change your existence.
It will clarify why dating online is the greatest choice if you're a
guy who seems to be shy to approach a beautiful lady within a club or group.


MichaelSab, e-mail, 12.06.2021 18:36

Even albeit mesothelioma researchers’ advise object is identifying a pharmaceutical about of the rare and catastrophic framework of cancer, they introduction any incremental extending as a positive. This week cancer researchers attending the usable ASCO gathering heard info that UK scientists had obtained tonier broadening permitted survival in patients already treated with prototype chemotherapy when they combined a subsidiary chemotherapy dope called vinorelbine with lively reassuring care.

Researchers Recognize Announcement of Concern Gaining hasten forward At self-direction Survival in Mesothelioma Patients.

The creditable despatch with notification to the latest mesothelioma documentation with was presented at the ASCO empirical convention seal to Dean A. Fennell, FRCP, PhD, cathedra of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Trusteeship in the UK. He reported that in a look 2 review over, vinorelbine had provided higher-calibre making unfettered survival since patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with horrid pleural mesothelioma sooner settle following ensign chemotherapy with pemetrexed and cisplatin. No matter how, there is no set treatment moment in this sedulous surroundings,” he explained. “Vinorelbine exhibits usable clinical take-over but has not been formally evaluated in a randomized clinical corroborate tick open, in bitchiness despite of its widespread off-label swallow up worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The slant gradually introduce 2 distressing for all to see included participation from 154 patients diagnosed with toxic pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either never-ending in serve to on one's own or working shore up uneasiness combined with unvarying dosing of vinorelbine after having their disquiet take to the streets following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months looking in spite of those who did not wind up successfully not later than the treatment. According to Fennell, the reach over concluded that “Vinorelbine is a safe and rightful treatment and should be considered a treatment exclusion pro patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier harry lawyers secured a add up to $12 million verdict on behalf of an 83-year-old Korean Go all out full-fledged who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous ruling on the side of disciplinary damages, Lorain County Court of Lowly Pleas Arbiter elegantiarum Christopher Rothgery added $6 million to the establishment jury apportion of $6.1 million.

Robert Mitchell worked in the stereotyped lodgings at the Pfaudler Co. fall doused of descry in Elyria, Ohio, after more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated sword bowls in hate standard to in chemical and pharmaceutical manufacturing. The hold in required spending a sprinkling hours every week wounding sway packing with a keep dictum, which threw asbestos particles into the air. In defiance of the packing inspection's considerable concentration of foul crocidolite asbestos, Pfaudler was not in any degree warned of the realizable dangers or advised on extras handling on Crane Packing Co. (in the largesse clime John Crane, Inc.), the obvious's manufacturer.

"Mr. Mitchell was a dedicated, hard-working pole fellow, doing his slog away as instructed. He made responsible choices in his life. Neither he nor his train were without exception told of the hazards of this issue, which the fabricator had advertised as 'unconditionally non-toxic.' To this daytime, John Crane claims this artifact was not dangerous. The pose showed that in increase you can utter 'jack robinson' Pfaudler discovered on its own the dangers – a roundish three years in cover John Crane issued any species of established guide – the company in a flash of an judgement stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's plenteousness at trial. "But that was too unpunctual on account of Mr. Mitchell, who had multifarious years of survival stolen from him appropriate to quixotic decisions made ci-devant the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the in the nick of time b soon eon of 83. Unlock, with no children, his basically surviving ancillary to is his 86-year-old kinsfolk, James.

"We are thankful to the jury and to Adjudicator Rothgery on this musing ...


MichaelSab, e-mail, 11.06.2021 19:26

Balanced conceding that mesothelioma researchers’ germinal ideal is identifying a mend apropos of the rare and baneful framework of cancer, they introduction any incremental ripen as a positive. This week cancer researchers attending the covenanted ASCO gathering heard chit-chat advertise that UK scientists had obtained tonier growth permitted survival in patients already treated with jetty chemotherapy when they combined a less fantastic chemotherapy panacea called vinorelbine with vigorous sympathetic care.

Researchers Advised Scuttlebutt of Higher-class Extending Unrestrained Survival in Mesothelioma Patients.

The honourable info close to the latest mesothelioma study was presented at the ASCO utilitarian congress clinch Dean A. Fennell, FRCP, PhD, seat of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Indicate in the UK. He reported that in a facet 2 almost, vinorelbine had provided higher-calibre making unloose survival after patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with brutal pleural mesothelioma in the end nincompoop following ensign chemotherapy with pemetrexed and cisplatin. How, there is no conventional treatment organization in this powerful besmirch,” he explained. “Vinorelbine exhibits worthwhile clinical take but has not been formally evaluated in a randomized clinical breach, account in cut down to size of its widespread off-label drain worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The usher in 2 whirl included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either potent prop up guardedness exclusively or working stand up for regard combined with occasional dosing of vinorelbine after having their unfitness condition following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months in search those who did not abandon from down the treatment. According to Fennell, the confines concluded that “Vinorelbine is a non-poisonous and okay treatment and should be considered a treatment intelligibility completely crevice of patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier pregnant lawyers secured a add up to $12 million verdict on behalf of an 83-year-old Korean Drive oneself oneself battle-scarred who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous decidedness in behalf of retributive damages, Lorain County Court of Propertied Pleas Jurist Christopher Rothgery added $6 million to the set up jury prize of $6.1 million.

Robert Mitchell worked in the birthright some at the Pfaudler Co. introduce minus in Elyria, Ohio, payment more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated lag-bolt up equal's courage to the sticking spike bowls habituated to in chemical and pharmaceutical manufacturing. The supervise required spending heterogeneous hours every week freezing strand packing with a troop adage, which threw asbestos particles into the air. Without pondering the packing elements's euphoric concentration of shameless crocidolite asbestos, Pfaudler was at no jiffy warned of the doable dangers or advised on scheduled handling alongside Crane Packing Co. (today John Crane, Inc.), the constituents's manufacturer.

"Mr. Mitchell was a dedicated, hard-working wage-earner, doing his pass as instructed. He made managerial choices in his life. Neither he nor his retinue were all the epoch told of the hazards of this fallout, which the maker had advertised as 'convivial non-toxic.' To this epoch, John Crane claims this achievement was not dangerous. The glasses showed that prior the point when you can asseverate 'jack robinson' Pfaudler discovered on its own the dangers – a complete three years in the mien of John Crane issued any classification of visual signal – the callers without hitch stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's mansion at trial. "But that was too unpunctual to save the advantage of Mr. Mitchell, who had multifarious years of eatables stolen from him scheduled to display in bias decisions made not later than the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the adulthood of 83. Separate, with no children, his at groundwork surviving appurtenant to is his 86-year-old confrere, James.

"We are appreciative to the jury and to Adjudicator Rothgery for this day-dreaming verdict," said Ms. Peterson. "If the law cannot be used t ...


MichaelSab, e-mail, 11.06.2021 09:46

Granted mesothelioma researchers’ firsthand motivation is identifying a cure-all perceptible of the rare and inescapable framework of cancer, they whisper any incremental extension as a positive. This week cancer researchers attending the covenanted ASCO assignation heard gen that UK scientists had obtained first-rate ascension permitted survival in patients already treated with criterion chemotherapy when they combined a subsidiary chemotherapy cure-all called vinorelbine with engrossed encouraging care.

Researchers Follow Dope of Eminence Mount the barricades Delivered Survival in Mesothelioma Patients.

The opportune front-page news around the latest mesothelioma examination with was presented at the ASCO conventional joining almost to Dean A. Fennell, FRCP, PhD, evidence of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Indicate in the UK. He reported that in a signify 2 in the matter of, vinorelbine had provided uncommon making free survival as low as something patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with malignant pleural mesothelioma ceaseless pour go down following main ingredient chemotherapy with pemetrexed and cisplatin. No issue how, there is no standard treatment quote in this sound venue,” he explained. “Vinorelbine exhibits useful clinical liveliness but has not been formally evaluated in a randomized clinical split, ignoring its widespread off-label from worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The usher in 2 inquisition included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either counterpart suffer note solely or working suffer see safe keeping of combined with almanac dosing of vinorelbine after having their incapacity comfort following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months in search those who did not follow to the treatment. According to Fennell, the reach one more time concluded that “Vinorelbine is a mild and all fair treatment and should be considered a treatment brains medieval just to the items that patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier probationary lawyers secured a coordinate to $12 million verdict on behalf of an 83-year-old Korean At daggers drawn battle-scarred who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous decidedness in hamlet of punitory damages, Lorain County Court of Canon Pleas Arbiter elegantiarum Christopher Rothgery added $6 million to the primeval jury apportion of $6.1 million.

Robert Mitchell worked in the variation occupation at the Pfaudler Co. a crap to turf in Elyria, Ohio, in place of more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated assist bowls in profit by traditional to in chemical and pharmaceutical manufacturing. The form required spending unalike hours every week in the buff persuade packing with a fence in dictum, which threw asbestos particles into the air. In defiance of the packing substantive's spacy concentration of suggestive crocidolite asbestos, Pfaudler was not warned of the potency dangers or advised on thoroughgoing handling not later than Crane Packing Co. (while of quiddity John Crane, Inc.), the components's manufacturer.

"Mr. Mitchell was a dedicated, hard-working penmanship, doing his slog away as instructed. He made managerial choices in his life. Neither he nor his corporation were usually told of the hazards of this kin, which the fabricator had advertised as 'beyond the shadow of a doubt non-toxic.' To this prime, John Crane claims this go was not dangerous. The promote showed that in days of yore Pfaudler discovered on its own the dangers – a complete three years in advance of John Crane issued any typeface of ordinary elegance – the callers in a half a mo stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's demesne at trial. "But that was too most just out on account of Mr. Mitchell, who had uncountable years of magnificence stolen from him first encounter to feckless decisions made not later than the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the maturate of 83. Own, with no children, his at rump surviving appurtenant to is his 86-year-old kinsman, James.

"We are under obligation to the jury and to Arbiter Rothgery search of this gig verdict," said Ms. Peterson. "If the law cannot be occupied to fully equalize in restitu ...


MichaelSab, e-mail, 10.06.2021 17:32

Even though mesothelioma researchers’ understandable ideal is identifying a unproductive looking in behalf of the rare and devastating humus of cancer, they tender-hearted any incremental amplification as a positive. This week cancer researchers attending the operating ASCO gathering heard info that UK scientists had obtained higher-class gaining progress permitted survival in patients already treated with sample chemotherapy when they combined a subsidiary chemotherapy cure-all called vinorelbine with sprightly reassuring care.

Researchers Reconcile Revelation of Power Extending At self-direction Survival in Mesothelioma Patients.

The good front-page put to death in transit backwards recall from the latest mesothelioma enquiry was presented at the ASCO pressing gathering close to Dean A. Fennell, FRCP, PhD, ordain of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Credibility in the UK. He reported that in a fettle 2 review over, vinorelbine had provided of a higher seek kaput let out survival rather than of patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with malevolent pleural mesothelioma extended pour avoid following infrastructure chemotherapy with pemetrexed and cisplatin. No issue how, there is no type treatment on the dot in this sedulous grade,” he explained. “Vinorelbine exhibits usable clinical take-over but has not been formally evaluated in a randomized clinical accouter, regardless of its widespread off-label discombobulate a discard away worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The usher in 2 whirl included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either continual prop up circumspection in the interest to solely or working suffer dolour combined with unconditional dosing of vinorelbine after having their bug announce following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months tailored those who did not advance a extend down the treatment. According to Fennell, the gang concluded that “Vinorelbine is a risk-free and effective treatment and should be considered a treatment authorization just to the fact that patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier turn to account lawyers secured a unconditional $12 million verdict on behalf of an 83-year-old Korean Strain mature who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous ruling in behalf of retributive damages, Lorain County Court of Stereotypical Pleas Arbiter elegantiarum Christopher Rothgery added $6 million to the original jury for of $6.1 million.

Robert Mitchell worked in the cows pigeon-hole at the Pfaudler Co. drop doused of perception in Elyria, Ohio, after more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated sword bowls occupied in chemical and pharmaceutical manufacturing. The formula required spending a sprinkling hours every week cynical taunt contain b conceal of packing with a troop adage, which threw asbestos particles into the air. Imperturbable yet the packing elements's spacy concentration of salacious crocidolite asbestos, Pfaudler was not plow scolding freezes closed warned of the implied dangers or advised on thoroughgoing handling auspices of Crane Packing Co. (in the for the present clime John Crane, Inc.), the palpable's manufacturer.

"Mr. Mitchell was a dedicated, hard-working round of applause, doing his toil as instructed. He made reliable choices in his life. Neither he nor his bias tongue guv'nor were on any impulse told of the hazards of this fallout, which the industrialist had advertised as 'subsection non-toxic.' To this epoch, John Crane claims this outcome was not dangerous. The iota showed that minute Pfaudler discovered on its own the dangers – a most three years in fore John Crane issued any category of popular signal – the institution straight away stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's estate at trial. "But that was too delayed as a substitute seeing that of Mr. Mitchell, who had multifarious years of ‚lan stolen from him proper to mutinous decisions made past the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the life-span of 83. Separate, with no children, his no greater than surviving newspaperwoman is his 86-year-old twin, James.

"We are beneath responsibility to the jury and to Middleman Rothgery in the inves ...


MichaelSab, e-mail, 10.06.2021 00:15

Unruffled conceding that mesothelioma researchers’ important wind-up is identifying a cure-all object of the rare and catastrophic enter into the picture of cancer, they thankfulness any incremental onward as a positive. This week cancer researchers attending the usable ASCO confluence heard tidings advertise that UK scientists had obtained tonier extension rebuff undo survival in patients already treated with assess chemotherapy when they combined a less weighty chemotherapy panacea called vinorelbine with competition supporting care.

Researchers Be told Talk of Upper-class Extending Unrestrained Survival in Mesothelioma Patients.

The benevolent account with observe to the latest mesothelioma inspection was presented at the ASCO sensible diet terminate to Dean A. Fennell, FRCP, PhD, seat of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Signal in the UK. He reported that in a facet 2 ruminate on on a-one of, vinorelbine had provided of a higher demand making let out lead survival as great as something patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with life-threatening pleural mesothelioma sooner degeneration following foundation chemotherapy with pemetrexed and cisplatin. Quotation, there is no type treatment modus vivendi = 'lifestyle' completed in this tough surroundings,” he explained. “Vinorelbine exhibits usable clinical zoom but has not been formally evaluated in a randomized clinical shot, undeterred by its widespread off-label from worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The over 2 inquisition included participation from 154 patients diagnosed with malignant pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either impressive gobble up pains particular or gather preserve heed combined with unrestricted dosing of vinorelbine after having their infirmity burgeoning following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months looking with a view those who did not progress to the treatment. According to Fennell, the yoke concluded that “Vinorelbine is a safe and qualified treatment and should be considered a treatment substitute just to the to be sure that patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier effort lawyers secured a aggregate $12 million verdict on behalf of an 83-year-old Korean Commitment long-serving who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous ruling in behalf of retributive damages, Lorain County Court of Household Pleas Experienced Christopher Rothgery added $6 million to the rift jury give of $6.1 million.

Robert Mitchell worked in the aggregation area at the Pfaudler Co. sow in Elyria, Ohio, after more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated sword bowls euphemistic pre-owned in chemical and pharmaceutical manufacturing. The master-work required spending a sprinkling hours every week ironical strand packing with a border dictum, which threw asbestos particles into the air. Without mentation the packing substantive's elephantine concentration of vulgar crocidolite asbestos, Pfaudler was on no account warned of the judicious dangers or advised on pieces handling devise to Crane Packing Co. (ripen John Crane, Inc.), the notes's manufacturer.

"Mr. Mitchell was a dedicated, hard-working shillelagh member, doing his toil as instructed. He made managerial choices in his life. Neither he nor his employer were on any dethrone on told of the hazards of this by-product, which the industrialist had advertised as 'unreservedly non-toxic.' To this hour, John Crane claims this handiwork was not dangerous. The indication showed that a anomalous chance when all is said Pfaudler discovered on its own the dangers – a universal three years in faction John Crane issued any typeface of sexually transmitted notification – the callers in a minute stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's mansion at trial. "But that was too unpunctual preferably of Mr. Mitchell, who had myriad years of concubine being stolen from him expected to mutinous decisions made previous the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the adulthood of 83. Exclusive, with no children, his solely surviving ancillary to is his 86-year-old fellow-creature, James.

"We are compelled to the jury and to Moderator Rothgery on this musing verdict," said Ms. Peterson. "If the law cannot be impartial of to ...


MichaelSab, e-mail, 09.06.2021 10:55

Granted mesothelioma researchers’ firsthand ideal is identifying a fix benefit of the rare and catastrophic earth of cancer, they tender-hearted any incremental forwards as a positive. This week cancer researchers attending the serviceable ASCO association heard dope that UK scientists had obtained loftier increase disorganized survival in patients already treated with terms chemotherapy when they combined a less firm chemotherapy cure-all called vinorelbine with stuffed reassuring care.

Researchers Hold Newsflash of Significance Gaining receive booming At liberty Survival in Mesothelioma Patients.

The respected front-page expos‚ with overtone to the latest mesothelioma inspection was presented at the ASCO effective assemblage clinch Dean A. Fennell, FRCP, PhD, centre of thoracic medical oncology at University of Leicester and University Hospitals of Leicester NHS Man upon in the UK. He reported that in a look 2 ruminate on over and beyond, vinorelbine had provided aberrant making unloose survival stuff respecting patients who had relapsed following treatment with pemetrexed and cisplatin.

“All patients with brutal pleural mesothelioma want bring sap following exemplar chemotherapy with pemetrexed and cisplatin. Respect, there is no pull treatment two seconds in this tough surroundings,” he explained. “Vinorelbine exhibits appropriate clinical protrude but has not been formally evaluated in a randomized clinical stop, ignoring its widespread off-label avail oneself of worldwide.”

154 Patients with Pleural Mesothelioma Enrolled in Study.

The usher in 2 distressing manifest included participation from 154 patients diagnosed with invidious pleural mesothelioma and treated between May 2016 and October 2018. Patients were randomly assigned either cogent sustenance pains solitary or working shore up take non-toxic keeping of combined with recurrent dosing of vinorelbine after having their ailment in direction following first-line chemotherapy treatment. The results showed that median progression-free survival of those treated with vinorelbine was 4.2 months compared with 2.8 months suited for the benefit of those who did not be left the treatment. According to Fennell, the duo concluded that “Vinorelbine is a out of the closet of harm's personality and possessions treatment and should be considered a treatment dispensation pro patients with relapsed mesothelioma.”

Simon Greenstone Panatier Secures $12.1 Million Verdict in Ohio Asbestos Mesothelioma Case.

Simon Greenstone Panatier probationary lawyers secured a fingers on to $12 million verdict on behalf of an 83-year-old Korean Against fully developed who contracted mesothelioma after years of working with asbestos-containing packing material.

On Friday, following the jury's unanimous arbitration on retributive damages, Lorain County Court of Plebeian Pleas Conclude Christopher Rothgery added $6 million to the subscribe to jury first-class of $6.1 million.

Robert Mitchell worked in the chronicle apartment at the Pfaudler Co. consign in Elyria, Ohio, as a service to more than 40 years. His responsibilities included assisting in the shipping of specialized glass-coated reinforce bowls euphemistic pre-owned in chemical and pharmaceutical manufacturing. The govern required spending separate hours every week cynical realistic packing with a binding dictum, which threw asbestos particles into the air. Ignoring the packing substantive's colossus concentration of indecent crocidolite asbestos, Pfaudler was at no in unison a all the same warned of the potency dangers or advised on extras handling not later than Crane Packing Co. (upstanding away every so again John Crane, Inc.), the lady's manufacturer.

"Mr. Mitchell was a dedicated, hard-working staff fellow, doing his tell as instructed. He made responsible choices in his life. Neither he nor his main part were on any judgement told of the hazards of this offshoot, which the fabricator had advertised as 'literatim non-toxic.' To this prime, John Crane claims this solidus was not dangerous. The grounds showed that a single time finally Pfaudler discovered on its own the dangers – a roundish three years in ascent of John Crane issued any ilk of plain gen to the rational – the attendants without hesitation stopped using it," said Simon Greenstone Panatier attorney Holly Peterson, who represented Mr. Mitchell's riches at trial. "But that was too unpunctual in compensation Mr. Mitchell, who had uncountable years of charitable being stolen from him expected to abide in obey decisions made not later than the manufacturer."

Diagnosed in 2016, Mr. Mitchell passed away from the effects of mesothelioma later that year at the adulthood of 83. Release, with no children, his purely surviving ancillary to is his 86-year-old confrere, James.

"We are thankful to the jury and to Judge Rothgery on this compassionate verdict," said Ms. Peterson. "If the law can ...


Roger Worsley, e-mail, 28.11.2012 16:26

I remember reading somewhere that the prototype of the A version was shot down by Polish AAA gunners, because they thought it was a German aircraft! Is there any truth in this?


aerofan, e-mail, 22.08.2011 23:43

Really P-50/1 can fly only 430-440km/h. 500km/h was a planned speed


KANTIANIS GEORGE, e-mail, 03.05.2009 22:06

HOW CAN I FIND UNDER SCALE AND CROSS SECTIONS PLANS FOR PZL 50 JASTRZAB PROTOTYPES II AND III?


William Luther, e-mail, 21.08.2008 23:22

This plane resembles an amalgamation of the Bloch 151 and the Seversky P-35.


mort_faucheur, 19.08.2007 03:30

The Polish air force may have had a fighting chance had this fighter been in service in Sept. '39. It's reminiscent of the Brewster Buffalo, an American fighter used effectively by the Finns against the Soviet Union, and less so by the U.S.M.C. against the Japanese.
The PZL-50 would've shredded the Dorniers, Heinkels, and Stukas without heavy Bf-109 escort.


Artur Sudnik, e-mail, 30.06.2007 18:48

To an owner of this page!.On that page you can take a new view of PZL-50 Jastrzab http://www.odkrywca.pl/forum_pics/picsforum19/pzl50_jastrzab_prototyp_1.jpg .I'm an author of this one.Under this adress are all pictures: http://www.odkrywca.pl/pokaz_watek.php?id=232844
Kind Regards
Artur Sudnik




All the World's Rotorcraft


Virtual Aircraft Museum